---
trial_id: 830
discovery_date: 2022-05-17 13:05:55.714654
date: 2022-05-17 13:05:55.714654
title: "Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy"
summary: |
  <b>Condition</b>:    Active Secondary Progressive Multiple Sclerosis<br /><b>Intervention</b>:    Other: siponimod<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05376579?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-05-17 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Active Secondary Progressive Multiple Sclerosis<br /><b>Intervention</b>:    Other: siponimod<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>